The Nasdaq 100 Index has slumped into a technical correction this year, falling by over 16% from its highest level in January. It has crashed to a low of $18,520, its lowest level since August 9 of last year.
The tech-heavy index has crashed as concerns about the American economy and the artificial intelligence (AI) sector continued. Just this week, it was reported that Microsoft was reducing its investments in data centers, a sign that the industry was softening.
The Nasdaq 100 index has also crashed because of the ongoing trade war between the United States and other trading partners like China, the European Union, and Canada. Analysts warn that many technology companies could become retaliatory targets by these trading partners.
Indeed, many well-known Nasdaq 100 index stocks have crashed this year. The worst performers are names like Trade Desk, Marvell Technology, On Semiconductor, Datadog, Broadcom, and MongoDB. This article explores some of the top-performing Nasdaq 100 index stocks this year.
Top Nasdaq 100 index stocks of 2025
Exelon Corp (EXC)
Exelon is the best-performing Nasdaq 100 stock this year, rising by over 25% since January. While its name is not a popular one, many Americans use its services since it is one of the biggest utility companies in the country.
Exelon owns brands like Atlantic City Electric, Commonwealth Edison, and PECO Energy Company. Its stock has jumped because of the rising demand from data centers, and the fact that it has a higher dividend yield than other firms. Its dividend yield stands at 3.50%.
Analysts expect that Exelon’s business will continue doing well this year. The average estimate is that its annual revenue will grow by 3.9% this year to $23.93 billion, followed by $24.57 billion next year.
Gilead Sciences (GILD)
Gilead Sciences is another top Nasdaq 100 index stock doing well this year. GILD stock is up by over 21% in 2025 and 60% in the last twelve months for three main reasons. First, as a pharmaceutical company, there is a likelihood that Donald Trump’s trade war will not impact it.
Second, the company’s business is doing well. The most recent numbers showed that Gilead’s sales, excluding Veklury, rose by 8% to $26.8 billion. Most of this growth was driven by its Trodelvy, a drug used to treat certain types of cancers. Its sales jumped by 24%, and analysts believe that the trend will continue.
Third, analysts are optimistic about its Lenacapavir drug, which will be used to treat certain HIV-1 illnesses. The company expects that this drug will receive full approval bythe summer of this year.
T-Mobile (TMUS)
T-Moble is another Nasdaq 100 index stock that has done well in the past few months, rising by over 21% this year. It has soared by 64% in the last twelve months and constantly beats its rivals like AT&T and Verizon.
T-Mobile has continued to take market share in the telco industry, and the end of the pricing wars has helped it boost its margins. The company’s 5G rollout has been one of the best, helped by its Sprint acquisition.
Further, the merger with Sprint helped it to boost its synergies, which has improved its profitability and cash flows. Also, the company’s business has not been affected by other slow-growing industries like cable and media that have affected their peers.
Read more: Here’s why T-Mobile stock price keeps beating AT&T and Verizon
Other top Nasdaq 100 shares
The other top Nasdaq 100 constituents this year are firms like Vertex Pharmaceuticals, Amgen, American Electric Power Company, PDD Holdings, and Mondelez. A closer look at all these firms shows that many of them have no presence in the slowing AI industry.
The post Top 3 Nasdaq 100 stocks rising as it moves into a correction appeared first on Invezz
